# Tag: Carlos Sanchez

- [Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen](https://brazilstockguide.com/insights/ems-ozivy-semaglutide-pen-anvisa-approval-brazil/) (2026-05-26): The first synthetic analogue of Ozempic approved in Brazil uses semaglutide and opens a new front in the multibillion-dollar GLP-1 drug market.